An urgent recall has gone out for a popular medical devices used by millions of Americans dealing with a chronic health ...

Wearables, or electronic devices worn to collect health-related data, are fast becoming a public health priority. U.S. Health ...

Whether you want to prevent diabetes or enhance your workout routine, this device could be key to staying in top shape.

It's been a busy couple of years for Tandem Diabetes Care (Nasdaq:TNDM) and it doesn't look like slowing down any time soon.

Thanks to his trusty Dexcom continuous glucose monitor (CGM), former boy band star Lance Bass is saying “bye bye bye” to ...

ACTON, Mass., June 10, 2025--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology, is excited to announce that the Omnipod® 5 App for iPhone is now compatible ...

In a real-world observational study of individuals with Type 2 diabetes not using insulin, Dexcom G7 use was associated with significantly reduced diabetes-related distress and increased adherence ...

Insulet (NasdaqGS:PODD) recently announced that its Omnipod® 5 App for iPhone is now compatible with the Dexcom G7 Continuous Glucose Monitoring System, enhancing its Automated Insulin Delivery ...

1 Dexcom State of Type 2 Report (US), Dexcom data on file, 2025. 2 Blake CL, et al. “Reduced Mortality Risk Associated with Dexcom rtCGM Compared to SMBG Among People with T2D on Any Insulin ...

DexCom’s product innovation remains a key driver of its market position. The recent approval of the G7 15-Day Continuous Glucose Monitoring system is a significant milestone for the company.